1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow MSI: new trials by email Literature Review of MSI trials Research Report on MSI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer Monalizumab/MEDI5257 - MSI, dMMR Colorectal Cancer | Phase 2 | Withdrawn | Assistance Publique - Hôpitaux de Paris | 2023-12-01 | 2026-04-06 |
Neoplasms (1)
monalizumab (1)
Assistance Publique - Hôpitaux de Paris (1)
France (1)